Judicial Panel on Multidistrict Litigation Issues Order on Glucagon-Like Peptide-1 Receptor Agonists Products Liability Litigation (MDL No. 3094)
December 13, 2024
December 13, 2024
WASHINGTON, Dec. 13 -- The Judicial Panel on Multidistrict Litigation issued the following order (MDL No. 3094) on Dec. 12, 2024:
* * *
In Re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
TRANSFER ORDER
Before the Panel: Plaintiff in the Wolfe action listed on Schedule A moves under 28 U.S.C. Sec. 1407(c) to transfer Wolfe to the District of South Carolina for inclusion in MDL No. 3094. Defendants Novo Nor . . .
* * *
In Re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
TRANSFER ORDER
Before the Panel: Plaintiff in the Wolfe action listed on Schedule A moves under 28 U.S.C. Sec. 1407(c) to transfer Wolfe to the District of South Carolina for inclusion in MDL No. 3094. Defendants Novo Nor . . .